Zobrazeno 1 - 9
of 9
pro vyhledávání: '"M. V. Seregina"'
Autor:
L. P. Mikhailova, M. V. Seregina
Publikováno v:
Bulletin of Experimental Biology and Medicine. 133:415-417
Acute and chronic toxicities of plant extracts for external use were studied on a model of cell monolayer. This method detects the toxic dose of the agent during the first stage of the study; the activity of this dose and severity of damaging effect
Autor:
O. V. Kuzmin, M. V. Seregina
Publikováno v:
Discrete Mathematics and Applications. 20
Publikováno v:
Bulletin of the Russian Academy of Sciences Division of Chemical Science. 41:807-810
The interaction ofortho-, meta-carboranes with tri- and tetrachloroethylene was investigated at 380°C in the absence of radical sources and at 150–200°C in the presence oftert-butyl peroxide.
Autor:
A G, Zhiliaev, M V, Seregina
Publikováno v:
Voenno-meditsinskii zhurnal. 323(6)
Autor:
M V, Seregina, L P, Mikhailova
Publikováno v:
Bulletin of experimental biology and medicine. 133(4)
Acute and chronic toxicities of plant extracts for external use were studied on a model of cell monolayer. This method detects the toxic dose of the agent during the first stage of the study; the activity of this dose and severity of damaging effect
Publikováno v:
Bulletin of the Russian Academy of Sciences Division of Chemical Science. 41:804-806
The interaction of carboranes-12 with 1,2-dichloroethylene was investigated at 150–200°C in the presence oftert-butyl peroxide as an initiator.
Autor:
L. M. Bronstein, E. Sh. Mirzoeva, M. V. Seregina, P. M. Valetsky, S. P. Solodovnikov, R. A. Register
Publikováno v:
ACS Symposium Series ISBN: 9780841233928
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::75048e6d7405771fe6a09ffda89c5b38
https://doi.org/10.1021/bk-1996-0622.ch006
https://doi.org/10.1021/bk-1996-0622.ch006
Autor:
I N, Bokarev, V A, Lusov, A P, Golikov, V V, Ptushkin, T V, Zvereva, M P, Savenkov, M V, Seregina
Publikováno v:
Folia haematologica (Leipzig, Germany : 1928). 115(4)
273 patients suffering from ischemic heart disease were treated with Anturan for one year at a daily dosage of 800 mg. The number of cardiovascular complications was significantly reduced, compared to the control group.
Autor:
GAN-MOOG CHOW, KENNETH E. GONSALVES, W. M. Tolles, L. de Juan, J. Fernández de la Mora, M. R. Zachariah, R. D. Shull, B. K. McMillin, P. Biswas, Wenhua Zhu, Sotiris E. Pratsinis, M. Samy El-Shall, Shautian Li, Daniel Graiver, Udo Pernisz, L. M. Bronstein, E. Sh. Mirzoeva, M. V. Seregina, P. M. Valetsky, S. P. Solodovnikov, R. A. Register, Arno Roescher, Martin Möller, L. Longenberger, G. Mills, Andrea B. R. Mayer, James E. Mark, G. Carlson, J. Kumar, F. Aranda, M. Jose-Yacaman, Michael A. Markowitz, Alok Singh, L. I. Halaoui, S. S. Kher, M. S. Lube, S. R. Aubuchon, C. R. S. Hagan, R. L. Wells, L. A. Coury, C. M. Lukehart, Stephen B. Milne, S. R. Stock, James E. Wittig, W. Yang, H. Inoue, Y. Nakazono, H. Samura, T. Saegusa, S. P. Rangarajan, C. C. Law, C. R. Feng, A. Garcia-Ruiz, Doron Levin, Stuart L. Soled, Jackie Y. Ying, Thomas J. Pinnavaia, Tie Lan, Zhen Wang, Hengzhen Shi, P. D. Kaviratna, John C. Hutchison, Rabin Bissessur, Duward F. Shriver, Hong Ding, Frank W. Harris, R. A. Andrievski, Isao Hasegawa, Yasutaka Nakane, Marie-Isabelle Baraton, Xiaoh